Filing Details

Accession Number:
0000921895-19-001552
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-17 16:06:19
Reporting Period:
2019-05-15
Accepted Time:
2019-05-17 16:06:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
707388 Digirad Corp DRAD Electromedical & Electrotherapeutic Apparatus (3845) 330145723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752852 J. David Noble C/O Digirad Corporation
1048 Industrial Court
Suwanee GA 30024
Coo; Interim Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-15 91,462 $0.00 166,462 No 4 M Direct
Common Stock Acquisiton 2019-05-17 8,538 $0.65 175,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Acquisiton 2019-05-15 274,386 $0.00 274,386 $0.00
Common Stock Restricted Stock Unit Disposition 2019-05-15 91,462 $0.00 91,462 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
274,386 No 4 A Direct
182,924 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
  2. This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date.
  3. The price reported in Column 4 is a weighted average price, rounded to nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.65 to $0.67, rounded to nearest cent, inclusive. Mr. Noble undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission,upon request, full information regarding the number of shares purchased and the purchase price at which such shares were purchased.
  4. On May 15, 2019, the Reporting Person was granted 274,386 Restricted Stock Units. As to this grant, one-third of the Restricted Stock Units are scheduled to vest on each of the grant date, May 15, 2020 and May 15, 2021, subject to the Reporting Person continuing to provide service through each such date.